UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis

Journal of cardiovascular magnetic resonance, 2018-01, Vol.20 (1), p.2-2, Article 2

2018

Volltextzugriff (PDF)

Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study

Annals of hematology, 2022-04, Vol.101 (4), p.831-836

2022

Volltextzugriff (PDF)

Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients

Annals of hematology, 2020-08, Vol.99 (8), p.1735-1740

2020

Volltextzugriff (PDF)

Clinical presentation and prognosis of light-chain amyloidosis patients with unmeasurable free light-chain levels

Annals of hematology, 2018-12, Vol.97 (12), p.2465-2470

2018

Volltextzugriff (PDF)

Long-Term Outcomes of Autologous Stem Cell Transplantation in Patients with Newly Diagnosed POEMS Syndrome

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.207.e1-207.e7

2024

Volltextzugriff (PDF)

At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment

Annals of hematology, 2017-12, Vol.96 (12), p.2089-2094

2017

Volltextzugriff (PDF)

Early or deferred treatment of smoldering multiple myeloma: a meta-analysis on randomized controlled studies

Cancer management and research, 2019-06, Vol.11, p.5599-5611

2019

Volltextzugriff (PDF)

Intestinal Mucosal-Associated Lymphoid Tissue Lymphoma Mimicked Cryptogenic Multifocal Ulcerous Stenosing Enteritis

Chinese medical journal, 2018-05, Vol.131 (9), p.1126-1127

2018

Volltextzugriff (PDF)

14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome

European journal of haematology, 2013-12, Vol.91 (6), p.490-496

2013

Volltextzugriff (PDF)

Pulmonary Erdheim-Chester disease successfully treated with vemurafenib

Annals of hematology, 2024-02, Vol.103 (2), p.673-675

2024

Volltextzugriff (PDF)

Long-term outcomes of newly diagnosed POEMS syndrome patients who received first-line lenalidomide-based therapy

Haematologica (Roma), 2024-06

2024

Volltextzugriff (PDF)

A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

Blood, 2023-05, Vol.141 (21), p.2654-2657

2023

Volltextzugriff (PDF)

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Circulation (New York, N.Y.), 2022-01, Vol.145 (1), p.8-17

2022

Volltextzugriff (PDF)

Daratumumab-based regimen for cold agglutinin disease refractory to therapy directing B-cell clone

Leukemia & lymphoma, 2024-03, Vol.65 (3), p.410-412

2024

Volltextzugriff (PDF)

Underlying IgM heavy chain amyloidosis in treatment-refractory IgA nephropathy: A case report

World journal of clinical cases, 2019-10, Vol.7 (19), p.3055-3061

2019

Volltextzugriff (PDF)

Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study

Haematologica (Roma), 2024-03

2024

Volltextzugriff (PDF)

Validation of the composite organ and hematologic response model for prognostic prediction in a Chinese light chain amyloidosis cohort

Leukemia & lymphoma, 2021-07, Vol.62 (8), p.1892-1896

2021

Volltextzugriff (PDF)

Posttreatment dFLC less than 10 mg/L predicts superior organ response and longer time to next treatment in newly diagnosed light-chain amyloidosis patients treated with bortezomib

Leukemia & lymphoma, 2021-03, Vol.62 (4), p.874-882

2021

Volltextzugriff (PDF)

Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis

Leukemia research, 2022-09, Vol.120, p.106917-106917, Article 106917

2022

Volltextzugriff (PDF)

Bortezomib-based chemotherapy reduces early mortality and improves outcomes in patients with ultra-high-risk light-chain amyloidosis: a retrospective case control study

Amyloid, 2019-04, Vol.26 (2), p.66-73

2019

Volltextzugriff (PDF)

Clinical presentation and prognostic analysis of Chinese patients with systemic light chain amyloidosis with liver involvement

Leukemia research, 2019-11, Vol.86, p.106226-106226, Article 106226

2019

Volltextzugriff (PDF)

Genomic profiling in amyloid light-chain amyloidosis reveals mutation profiles associated with overall survival

Amyloid, 2020-01, Vol.27 (1), p.36-44

2020

Volltextzugriff (PDF)

The clinical spectrum of IgM monoclonal gammopathy: a single center retrospective study of 377 patients

Leukemia research, 2016-07, Vol.46, p.85-88

2016

Volltextzugriff (PDF)

Clinical presentation and prognosis of immunoglobulin light-chain amyloidosis with high percentage of bone marrow plasma cells

Leukemia research, 2019-06, Vol.81, p.19-24

2019

Volltextzugriff (PDF)

Ischemic stroke in patients with POEMS syndrome

Blood advances, 2020-07, Vol.4 (14), p.3427-3434

2020

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(48)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis

Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study

Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients

Clinical presentation and prognosis of light-chain amyloidosis patients with unmeasurable free light-chain levels

Long-Term Outcomes of Autologous Stem Cell Transplantation in Patients with Newly Diagnosed POEMS Syndrome

At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment

Early or deferred treatment of smoldering multiple myeloma: a meta-analysis on randomized controlled studies

Intestinal Mucosal-Associated Lymphoid Tissue Lymphoma Mimicked Cryptogenic Multifocal Ulcerous Stenosing Enteritis

14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome

Pulmonary Erdheim-Chester disease successfully treated with vemurafenib

Long-term outcomes of newly diagnosed POEMS syndrome patients who received first-line lenalidomide-based therapy

A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Daratumumab-based regimen for cold agglutinin disease refractory to therapy directing B-cell clone

Underlying IgM heavy chain amyloidosis in treatment-refractory IgA nephropathy: A case report

Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study

Validation of the composite organ and hematologic response model for prognostic prediction in a Chinese light chain amyloidosis cohort

Posttreatment dFLC less than 10 mg/L predicts superior organ response and longer time to next treatment in newly diagnosed light-chain amyloidosis patients treated with bortezomib

Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis

Bortezomib-based chemotherapy reduces early mortality and improves outcomes in patients with ultra-high-risk light-chain amyloidosis: a retrospective case control study

Clinical presentation and prognostic analysis of Chinese patients with systemic light chain amyloidosis with liver involvement

Genomic profiling in amyloid light-chain amyloidosis reveals mutation profiles associated with overall survival

The clinical spectrum of IgM monoclonal gammopathy: a single center retrospective study of 377 patients

Clinical presentation and prognosis of immunoglobulin light-chain amyloidosis with high percentage of bone marrow plasma cells

Ischemic stroke in patients with POEMS syndrome

Suchergebnisse filtern